IQVIA Holdings Inc. (IQV) shares surged 7.57% in pre-market trading on Tuesday following the release of its better-than-expected second-quarter 2025 financial results and positive full-year guidance.
The healthcare data and analytics company reported adjusted earnings per share (EPS) of $2.81, surpassing the analyst consensus estimate of $2.77. Revenue for the quarter came in at $4.02 billion, also beating the expected $3.96 billion. The company's net income for the quarter stood at $266 million.
IQVIA's strong performance and optimistic outlook have boosted investor confidence. The company provided upbeat full-year 2025 guidance, projecting revenue between $16.1 billion and $16.3 billion, and adjusted EBITDA in the range of $3.75 billion to $3.825 billion. The adjusted EPS forecast for the full year is set between $11.75 and $12.05, indicating continued growth expectations. This positive outlook, coupled with the Q2 earnings beat, appears to be the primary driver behind the significant pre-market stock movement.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。